Fox Chase Cancer Center Presents In Vino Vita Benefit and Wine Auction

PHILADELPHIA, PA (April 22, 2014)—Fox Chase Cancer Center, in partnership with its Board of Associates, will be hosting the inaugural In Vino Vita Benefit and Wine Auction on Thursday, May 15, 2014 at the Ritz-Carlton Philadelphia (Ten Avenue of the Arts). The event, which will raise money for leading edge research and patient care at Fox Chase, offers attendees the opportunity to participate in an elegant and festive live auction, accompanied by premiere food and cocktails.

Stellar Fundraising Auctions of San Francisco, one of the nation's leaders in philanthropic auctions, will be part of the evening's entertainment.  Auctioneer Greg Quiroga will lead the event with humor, passion, and fantastic lots of wine, travel and experiences available to the highest bidders. Some of the live auction items that will be ripe for the picking include: tickets and backstage access to the Stand Up To Cancer annual telethon in Los Angeles; a stay at the luxurious Canyon Ranch Spa and Resort in Lenox, Massachusetts; a pair of impossible-to-find bottles of Screaming Eagle; a winemaking experience for up to ten people; more than 30 bottles of wine, comprised of Fox Chase’s stellar physicians and scientists favorites; and much more.

Also at the event, special guest Avram Hershko, MD, PhD, Nobel Laureate, will be awarded the 2014 Stanley Reimann Honor Award. The award is named in honor of Stanley P. Reimann, MD, who founded the Institute for Cancer Research, the original home of Fox Chase’s research enterprise, in 1927 and numerous milestones on the road to our understanding of cancer. Dr. Hershko, who is being awarded this honor because he embodies these same qualities of ingenuity and expertise, was awarded the 2004 Nobel Prize in Chemistry for his involvement in the discovery of ubiquitin-mediated protein degradation. He shared the award that year with Aaron Ciechanover, PhD, and Fox Chase’s Irwin I. Rose, PhD.
The ubiquitin-proteasome pathway has a critical role in maintaining the homeostasis of cells and is believed to be involved in the development and progression of diseases such as cancer, muscular and neurological diseases, and immune and inflammatory responses. Dr. Hershko is currently on sabbatical at Fox Chase, where he is researching how protein degradation is used to ensure that chromosomes are accurately segregated between two daughter cells during mitosis—a continuation of his celebrated work on the breakdown of proteins within cells.

Tickets for the event are $250 per person/$2,500 per table. Those interested in attending should register by visiting vinovita.org.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427